That’s fake news. Real news COSTS. Please turn off your ad blocker for our web site.
Our PROMISE: Our ads will never cover up content.
Michael Causey
Published: Tuesday, July 1, 2014 - 09:23 If someone out in there in the wild wonderful world of the web takes a potshot at your drug or device, the first thing to do is take a deep breath and think. Any crisis communications executive worth her salt will tell you it’s often best to let the attacker eat silence rather than draw more attention to their criticism or cheap shot.
But if the criticism is relentless, or damaging and unfair, if it looks like it’s gaining traction, then a measured response can be part of the solution. The FDA just released a guidance that it says “responds to (among other things) stakeholder requests for specific guidance regarding a firm’s voluntary correction of misinformation when that misinformation is created or disseminated by an independent third party.” In other words, how to fight back fairly. The short guidance is vague on specifics, though it does give us a “helpful” reminder that the Internet makes it much easier for third parties to easily disseminate information about your products and your company. The agency calls it user-generated content (UCG). I don’t mean to sound like an elitist snob, but this sounds kind of obvious to me. “I wouldn’t call this guidance useless... well, yes I would,” a medical device industry consultant told us. He asked to remain anonymous on the off chance that anyone at the FDA ever reads this blog. Is the guidance helpful? You be the judge. Here’s how the FDA advises a drug or device company to address negative or inaccurate claims online: I suppose writing all of this down somewhere doesn’t hurt anything except the trees killed when it is printed out. Still, it feels a bit like the FDA is talking down to future winners of the Darwin Awards. That’s the “prize” named in honor of Charles Darwin that commemorates those who “improve our gene pool by removing themselves from it,” such as this winner: In 2000, a motorcycle taxi driver challenged his neighbor to stand beneath a hornets’ nest, while two men pelted it with stones. The 53-year-old man should have known better, but he had a local reputation as a strong man to uphold. He stood beneath the nest and the pelting commenced. The man endured the pain of countless stinging hornets before expiring from the toxic injections. To be fair, if you need an FDA guidance to tell you to “be accurate,” I’d also say you may need a reminder to stay away from hornets or men holding stones. Otherwise, there’s no harm bookmarking this new guidance in your computer. But don’t print it out, please. It’s not fair to the trees. First published June 24, 2014, on the AssurX blog. Quality Digest does not charge readers for its content. We believe that industry news is important for you to do your job, and Quality Digest supports businesses of all types. However, someone has to pay for this content. And that’s where advertising comes in. Most people consider ads a nuisance, but they do serve a useful function besides allowing media companies to stay afloat. They keep you aware of new products and services relevant to your industry. All ads in Quality Digest apply directly to products and services that most of our readers need. You won’t see automobile or health supplement ads. So please consider turning off your ad blocker for our site. Thanks, James Michael Causey’s been a journalist since he started his own neighborhood newspaper in the 1970s. In addition to quizzing FDA officials for the past 10+ years, he’s also interviewed political satirist Art Buchwald, FCC Chairman Reed Hundt, SEC Chairwoman Mary Schapiro, and is the past president of the Washington Independent Writers. Causey is the editor and publisher of eDataIntegrityReport.com and is a contributing writer on the AssurXblog.Charles Darwin, Social Media, and the FDA’s New Guidance
The FDA’s advice on handling criticism seems a bit obvious
• Be relevant and responsive to the misinformation
• Be limited and tailored to the misinformation
• Be nonpromotional in nature, tone, and presentation
• Be accurate
• Be consistent with the FDA-required labeling for the product
• Be supported by sufficient evidence, including substantial evidence, when appropriate, for prescription drugs
• Either be posted in conjunction with the misinformation in the same area or forum (if posted directly to the forum by the firm), or reference the misinformation and intend to be posted in conjunction with the misinformation (if provided to the forum operator or author)
• Disclose that the person providing the corrective information is affiliated with the firm that manufactures, packs, or distributes the product
Our PROMISE: Quality Digest only displays static ads that never overlay or cover up content. They never get in your way. They are there for you to read, or not.
Quality Digest Discuss
About The Author
Michael Causey
© 2023 Quality Digest. Copyright on content held by Quality Digest or by individual authors. Contact Quality Digest for reprint information.
“Quality Digest" is a trademark owned by Quality Circle Institute, Inc.